Present concepts of the mechanisms of hyposensitization

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 36, Issue 7, 1996, Pages 782-790

  Ponvert, Cl ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4;

ALLERGY; BASOPHIL; DESENSITIZATION; EOSINOPHIL; HELPER CELL; HUMAN; NONHUMAN; REVIEW; T LYMPHOCYTE SUBPOPULATION;

EID: 0030468772     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(96)80066-9     Document Type: Review

References (154)

1. Aalberse R.C., Van der Gaag R. & Van Leeuwen J. - Serologic aspects of IgG4 antibodies. I : prolonged immunization results in an IgG4-restricted response. J. Immunol., 1983, 130, 722-726.
2. Akoum H., Tsicopoulos A., Vorngt H. et al. - Modulation of IL-4 and IFN-γmRNA expression during rush venom immunotherapy. J. Allergy Clin. Immunol., 1995, 95, 306 (Abst. 661).
3. Akoum H., Tsicopoulos A., Vorngt H. et al. - Chemokine production by peripheral blood mononuclear cells during rush venom immunotherapy. J. Allergy Clin. Immunol., 1996, 97, 228 (Abst. 183).
4. Bernstein I.L., Michael J.G., Malkiel S. et al. - Immunoregulatory functions of specific immunoglobulins. II - Clinical evaluation of combined passive and active immunotherapy. Int. Arch. Allergy Appl. Immunol., 1979, 58, 30-37.
5. Birkner T., Rumpold H., Jarolim E. et al. - Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Allergy, 1990, 45, 418-426.
6. Bose R., Marsh D.G. & Delespesse G. - Anti-idiotypes to anti-Lol p I (Rye) antibodies in allergic and non allergic individuals. Influence of immunotherapy. Clin. Exp. Immunol., 1986, 66, 231-240.
7. Broman P. & Möller E. - Lymphocyte transformation by grass pollen allergens. A study of atopic patients receiving immunotherapy. Allergy, 1988, 43, 321-331.
8. Brunet C., Bedard P.M., Lavoie A. et al. - Allergic rhinitis to ragweed pollen. II - Modulation of histamine-releasing factor production by specific immunotherapy. J. Allergy Clin. Immunol., 1992, 89, 87-94.
9. Byron K.A., O'Brien R.M., Varigos G.A. & Wootton A.M. - Dermatophagoides pteronyssinus II- induced interleukin-4 and interferon-γ expression by freshly isolated lymphocytes of atopic individuals. Clin. Exp. Allergy, 1994, 24, 878-883.
10. Carini C. - IgE immune complexes in food allergy. Significance, pathogenicity and clinical considerations. Clin. Allergy, 1987, 17, 485-497.
11. Casale T.B., Bernstein I.L., Busse W.W. et al. - Recombinant human monoclonal anti-IgE therapy in allergic rhinitis. J. Allergy Clin. Immunol., 1996, 97, 199 (Abst. 67).
12. Castracane J.M. & Rocklin R.E. - Detection of human auto-antiidiotypic antibodies (Ab2). I : isolation and characterization of Ab2 in the serum of a ragweed immunotherapy treated patient. Int. Arch. Allergy Appl. Immunol., 1988, 86, 288-294.
13. Chabay R., De Lisi C., Hook W.A. & Siraganian R.S. - Receptor cross-linking and histamine release in basophils. J. Biol. Chem., 1980, 255, 4628-4635.
14. Cockroft D.W., Kalra S., Bhagat R. et al. - RhuMAb-E25, a humanized murine monoclonal anti-IgE antibody, inhibits the allergen-induced early asthmatic response (EAR). J. Allergy Clin. Immunol., 1996, 97, 315 (Abst. 532).
15. Corren J., Froelich J,. Schoenhoff M. et al. - Phase I study of anti-IgE recombinant humanized monoclonal antibody rhuMAb-E25 (E25) in adults with moderate to severe asthma. J. Allergy Clin. Immunol., 1996, 97, 245 (Abst. 251).
16. Creticos P.S., Marsh D.G., Proud D. et al. - Responses to ragweed pollen nasal challenge before and after immunotherapy. J. Allergy Clin. Immunol., 1990, 84, 197-205.
17. Creticos P.S. - Immunologic changes associated with immunotherapy. Immunol. Allergy Clin. N. Amer., 1992, 12, 13-37
18. Czech W., Stadler B.M., Schopf E. & Kapp A. - IgE autoantibodies in atopic dermatitis. Occurrence of different antibodies against the CH3 and the CH4 epitopes of IgE. Allergy, 1995, 50, 243-248.
19. Daeron M., Malber O., Latour S. et al. - Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J. Clin. Invest., 1995, 95, 577-585.
20. De las Marinas M.D., Sanz M.L., Dieguez I. et al. - IgE synthesis-suppressor factor. Modifications in the course of long-term immunotherapy. J. Invest. Allergol. Clin. Immunol., 1993, 3, 80-85.
21. De Lisi C. & Siraganian R.P. - Receptor cross-linking and histamine release. I - The quantitative dependance of basophil degranulation on the number of receptor doublets. J. Immunol., 1979, 122, 2286-2292.
22. De Lisi C. & Siraganian R.P. - Receptor cross-linking and histamine release. II - Interpretation and analysis of anomalous dose response patterns. J. Immunol., 1979, 122, 2293-2299.
23. De Monchy J.G.R., Dubois A.E.J., Barclay A. et al. - Immunotherapy with allergen immune complexes. Allergy, 1995, 50, 281-282 (Abst. P-0595).
24. Dieguez L., Sanz M.L. & Oehling A. - Influence of immunotherapy on histamine release and other immunological parameters of immediate hypersensitivity in pollinosis. J. Invest. Allergol. Clin. Immunol., 1993, 3, 64-71.
25. Djurup R. - The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy. Allergy, 1985, 40, 469-486.
26. Dorval G., Yang W.H., Goodfriend L. et al. - Circulating immune complexes may be associated with increased suppressor activity in atopic allergy. Clin. Immunol. Immunopathol., 1980, 16, 245-253.
27. Durham S.R., Kay A.B. & Hamid Q. - Changes in allergic inflammation associated with successful immunotherapy. Int. Arch. Allergy Immunol., 1995, 107, 282-284.
28. Eberlein-König B., Ullmann S., Thoman P. & Przybilla B. - Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization. Clin. Exp. Allergy, 1995, 25, 704-712.
29. Einarsson R., Dreborg S., Hammarström L. et al. - Monitoring of mite Dermatophagoides farinae allergen-specific IgG and IgG subclass distribution in patients on immunotherapy. Allergy, 1992, 47, 76-82.
30. Filion L.G. - Suppression of the IgE antibody response to ovalbumin in mice with a conjugate of ovalbumin and isologous gammaglobulins. Cell. Immunol., 1980, 54, 115-128.
31. Fritsché R., Borel Y. - Prevention of allergic sensitization to betalactoglobulin with conjugates made of lactoglobulins coupled to isologous immunoglobulin G. J. Allergy Clin. Immunol., 1994, 93, 778-786.
32. Gleich G.J., Zimmermann E.M., Henderson L.L. et al. - Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens : a six-year prospective study. J. Allergy Clin. Immunol., 1982, 70, 261-271.
33. Gonçalves da Costa P.S., Sahihi de Macedo M. & Perini A. - Suppression of mouse IgE response by immune complexes. J. Allergy Clin. Immunol., 1990, 86, 496-502.
34. Gondo A., Saeki N. & Tokuda Y. - IgG4 antibodies in patients with atopic dermatitis. Brit. J. Dermatol., 1986, 117, 301-310.
35. Grant J.A., Alam R. & Lett-Brown M.A. - Histamine-releasing factors and inhibitors. Historical perspectives and possible implications in human illness. J. Allergy Clin. Immunol., 1991, 88, 683-693.
36. Grattan C.E.H., Francis D.M., Hide M. et al. - Detection of circulating histamine-releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin. Exp. Allergy, 1991, 21, 695-704.
37. Haba S. & Nisonoff A. - Inhibition of IgE synthesis by anti-IgE. Role in long-term inhibition of IgE synthesis by neonatally administered soluble IgE. Proc. Natl. Acad. sci. USA, 1990, 87, 3363-3367.
38. Hall E. & Gault E.A. - Suppression of IgE responses by hyperimmune serum in rats. Immunology, 1987, 59, 577-581.
39. Hase N., Takai T., Hidika M. & Ohmori H. - Predominant suppression of anti-TNP IgE response in mice by monoclonal anti-TNP IgG1 antibody. Characterization of its mode of action by in vitro and in vivo studies. Int. J. Immunopharmac., 1994, 16, 787-794.
40. Hassner A. & Saxon A. - Isotype-specific human suppressor T cells for IgE synthesis activated by IgE-anti-IgE immune complexes. J. Immunol., 1984, 132, 2844-2849.
41. Haugaard L., Norregaard O.F.H. & Dahl R. - In hospital sting challenge in insect venom-allergic patients after stopping immunotherapy. J. Allergy Clin. Immunol., 1991, 87, 699-702.
42. Hauser U., Cromwell O., Frank E. & Bachert C. - Reduction of the cytokine content of nasal secretions as a result of allergen-specific immunotherapy. Allergy, 1995, 50, 276-277 (Abst. P - 0581).
43. Hedlin G., Graff-Lonnevig V., Heilborn H. et al. - Immunotherapy with cat and dog-dander extracts. II : in vivo and in vitro immunologic effects observed in a 1-year double-blind placebo study. J. Allergy Clin. Immunol., 1986, 77, 488-496.
44. Heusser C.H., Bews J., Brinkmann V. et al. - New concepts of IgE regulation. Int. Arch. Allergy Appl. Immunol., 1991, 94, 87-90.
45. Hook W.A., Berenstein E., Basciano L.A. et al. - Monoclonal antibodies to human IgE. Fed. Proc., 1981, 40, 968-971.
46. Hsieh K.H. - Altered interleukin-2 (IL-2) production and responsiveness after hyposensitization to house dust. J. Allergy Clin. Immunol., 1985, 76, 188-194.
47. Hsieh K.H. - Decreased production of interleukin-2 receptors after immunotherapy to house dust. J. Clin. Immunol., 1988, 8, 171-177.
48. Hsieh K.H. & Cheng-Koon N.G. - Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J. Allergy Clin. Immunol., 1993, 91, 650-657.
49. Hsieh K.H., Chou C.C. & Chiang B.L. - Immunotherapy suppresses the production of MCAF and augments the production of IL-8 in asthmatic children. J. Allergy Clin. Immunol., 1995, 95, 308 (Abst. 669).
50. Inganas M., Johansson S.G.O. & Bennich H. - Anti-IgE antibodies in human serum. Occurence and specificity. Int. Arch. Allergy Appl. Immunol., 1981, 65, 51-61.
51. Ishizaka T., Chang T.H., Taggart M. & Ishizaka K. - Histamine release from mast cells by antibodies against basophil leukemia cell membranes. J. Immunol., 1977, 119, 1589-1594.
52. Ito S., Shinomiya S. & Mikawa H. - Suppressive effects of IgE soluble immune complex on neutrophil chemotaxis. Clin. Exp. Immunol., 1983, 51, 407-412.
53. Jensem-Jarolim E., Vogel M., De Weck A.L. et al. - Anti-IgE autoantibodies mistaken for specific IgG. J. Allergy Clin. Immunol., 1992, 89, 31-43.
54. Johansson S.G.O. - Anti-IgE antibodies in human serum. J. Allergy Clin. Immunol., 1986, 77, 555-557.
55. Johnstone D.E. - Immunotherapy in the prevention of allergic disease. Ped. Asthma Allergy Immunol., 1987, 1, 15-30.
56. Jung C.M., Prinz J.C., Rieber E.P. & Ring J. - A reduction in allergen-induced FcεR2/CD23 expression on peripheral B cells correlates with successful hyposensitization in grass pollinosis. J. Allergy Clin. Immunol., 1995, 95, 77-87.
57. Jutel M., Müller U.R., Fricker M. et al. - The influence of ultrarush bee venom immunotherapy on histamine release and leukotriene secretion by blood basophils. Allergy, 1995, 50, 31 (Abst. OC - 069).
58. Jutel M., Pichler W.J., Skrbic D. et al. - Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-ε secretion in specific allergen-stimulated T cell cultures. J. Immunol., 1995, 154, 4187-4194.
59. Jutel M., Müller U.R., Rihs S. et al. - Blood basophils are influenced by ultrarush bee venom immunotherapy. Changes in histamine release and leukotriene secretion. J. Allergy Clin. Immunol., 1996, 97, 229 (Abst. 186).
60. Kanny G., Croisier A., Ragazzini J.P. & Moneret-Vautrin D.A. - Suivi immunologique des désensibilisations aux venins d'hyménoptères : intérêt du test de Maunsell. Rev. Fr. Allergol., 1993, 33, 274-283.
61. Karlsson R., Agrell B., Dreborg S. et al. - A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. II : in vitro results. Allergy, 1986, 41, 141-150.
62. Khan R.H., Szewczuk M.R. & Day J.H. - Bee venom anti-idiotypic antibody is associated with protection in bee-keepers and bee sting-sensitive patients receiving immunotherapy against allergic reactions. J. Allergy Clin. Immunol., 1991, 88, 199-208.
63. Kinikli G., Tulek N., Sercelik A. et al. - The change of serum interleukin-2 receptor levels during early phase of immunotherapy of patients with allergic rhinoconjonctivitis. Allergy, 1995, 50, 276 (Abst. P - 0580).
64. + B cells and clinical outcome in specific rush immunotherapy. Allergy, 1995, 50, 275-276 (Abst. P - 0578).
65. Kuna P., Alam R., Kuzminska B. & Rozniecki J. - The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma. Results of a double-blind placebo-controlled, randomized study. J. Allergy Clin. Immunol., 1989, 83, 816-824.
66. Kyriakopoulou G., Danilidis M., Fleva A. et al. - Significance of serum FcεRII receptor (sCD23) for the evaluation of allergic patients under immunotherapy. Allergy Clin. Immunol. News, 1994, S2, 767.
67. Lambin P., Bouzoumou A., Murietta M. et al. - Purification des IgG4 à partir du sérum d'un sujet désensibilisé et mesure de leur activité in vitro. CR. Réun. SFIAC, 1994, 1 Vol., p. 69 (Abst. 4).
68. Ledru E., Pestel J., Tsicopoulos A. et al. - Lymphocyte-mediated regulation of platelet activation during desensitization in patients with hymenoptera venom hypersensitivity. Clin. Exp. Immunol., 1988, 73, 198-203.
69. Leroy B.P., Bogden G., Lachapelle J.M. et al. - A novel therapy for atopic dermatitis with allergen-antibody complexes. A double-blind, placebo-controlled study. J. Am. Acad. Dermatol., 1993, 28, 232-239.
70. 2 fragments of specific antibodies. Brit. J. Dermatol., 1995, 132, 599-603.
71. Lesourd B., Paupe J., Thiollet M. et al. - Hymenoptera venom immunotherapy. I - Induction of T cell-mediated immunity by honeybee venom immunotherapy : relationship with specific antibody responses. J. Allergy Clin. Immunol., 1989, 83, 563-571.
72. Leynadier F., Murietta M., Michelen V. et al. - Rôle des anticorps bloquants sur les tests cutanés aux acariens. Presse Méd., 1987, 16, 1435-1436.
73. Leynadier F., Murietta A., Natta P. et al. - Evolution of specific IgG and IgG4 and blocking activity during mite rush immunotherapy. Immunol. Allergy Pract., 1990, 12 , 42-47.
74. Leynadier F. - Sous-classes d'IgG au cours de la désensibilisation. Conférence INTS (Paris, Jeudi 12 Mars 1992).
75. Liao T.N. & Hsieh K.H. - Altered production of histamine-releasing factor (HRF) activity and responsiveness to HRF after immunotherapy in children with asthma. J. Allergy Clin. Immunol., 1990, 86, 894-901.
76. Liccardi G., Cazzola M., Lobefalo G. et al. - The effect of 1-year immunotherapy on BHR and serum ECP levels in patients with respiratory allergy to parietaria judaica (PJ) pollen. Allergy, 1995, 50, 353 (Abst. P - 0813).
77. Lichtenstein L.M., Holtzman N.A. & Burnett L.S. - A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J. Immunol., 1968, 101, 317-324.
78. Lucas A.H. - IgG subclass-restricted immune responses to allergens. Semin. Immunopathol., 1990, 12, 385-400.
79. Lynch N.R., Durand P., Newcomb R.W. et al. - Influence of IgG antibody and glycopeptide allergens on the correlation between the radioallergosorbent test (RAST) and skin testing or bronchial challenge with alternaria. Clin. Exp. Immunol., 1975, 22, 35-46.
80. Machiels J.J., Buche M., Somville M.A. et al. - Complexes of grass pollen allergens and specific antibodies reduce allergic symptoms and inhibit the seasonal increase of IgE antibody. Clin. Exp. Allergy, 1990, 20, 653-660.
81. Machiels J.J., Somville M.A., Lebrun P.M. et al. - Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes. J. Clin. Invest., 1990, 85, 1024-1035.
82. Machiels J.J., Somville M.A., Jacquemin M.G. et al. - Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergy, 1991, 46, 335-348.
83. Maeyama K., Hochman R.J., Metzger H. & Beaven M.A. - Quantitative relationship between aggregation of IgE receptors, generation of intracellular signals, and histamine secretion in rat basophilic leukemia (2H3) cells. Enhanced response with heavy water. J. Biol. Chem., 1986, 261, 2583-2592.
84. Magdy M.E., Gamiel N. & El-Kenawy M. - Changes of interleukin-2 (IL-2) in allergic asthmatic children after three years immunotherapy. Allergy Clin. Immunol. News, 1994, S2, 768.
85. Magnusson C.G.M. - Major differences in specificity among naturally occuring human IgG-subclass anti-IgE autoantibodies. J. Allergy Clin. Immunol., 1995, 95, 1011-1019.
86. Malling H.J. & Djurup R. - Diagnosis and therapy of mould allergy. VII - IgG subclass response and relation to the clinical efficacity of immunotherapy with Cladosporium. Allergy, 1988, 43, 60-70.
87. McHugh S.H., Deighton J. & Ewan P.W. - Rush and conventional immunotherapy cause loss of Th2 and induction of Th1 responses. Studies over 1 year. Allergy, 1995, 50, 30 (Abst. OC - 067).
88. Michael J.G. & Bernstein I.L. - Immunoregulatory function of specific IgG. I : results in non atopic subjects. J. Immunol., 1978, 120, 652-654.
89. Moens M.N., Van Bever H.P., Stevens W.J. et al. - Influence of hyposensitization on soluble interleukin-2 receptor, eosinophil cationic protein, in vitro lymphocyte proliferation, in vitro lymphocyte adhesion, and lymphocyte membrane markers in childhood asthma. Allergy, 1994, 49, 653-688.
90. Möller C., Dreborg S. & Einarsson R. - Immunotherapy to deciduous tree pollens : specific IgE and IgG patterns. Clin. Allergy, 1987, 17, 551-562.
91. Müller U., Helbling A. & Bishof M. - Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy, 1989, 44, 412-418.
92. Müller W.D., Karameilov T., Fahlsch B. et al. - Analysis of human T cell clones reactive with group V grass pollen allergens. Int. Arch. Allergy Immunol., 1994, 105, 391-396.
93. Munoz F.J., Montersirin F.J., Escribano E. et al. - IL-4 and IFN-γ production by PBMC of atopic and non atopic subjects during and out the pollen season. Allergy, 1995, 50, 327 (Abst. P - 0733).
94. Nagata M., Shibasaki M., Sakamoto Y. et al. - Specific immunotherapy reduces the antigen-dependent production of eosinophil chemotactic activity from mononuclear cells in patients with atopic asthma. J. Allergy Clin. Immunol., 1994, 94, 160-166.
95. Nakagawa T. - The role of IgG subclass antibodies in the clinical response to immunotherapy in allergic disease. Clin. Exp. Allergy, 1991, 21, 289-296.
96. Nawata Y., Koike T., Hosokawa H. et al. - Anti-IgE autoantibody in patients with atopic dermatitis. J. Immunol., 1984, 135, 478-482.
97. Nawata Y., Koike T., Yanagisawa T. et al. - Anti-IgE autoantibody in patients with bronchial asthma. Clin. Exp. Immunol., 1984, 58, 348-356.
98. Nish W.A., Charlesworth E.N., Davis T.L. et al. - The effect of immunotherapy on the cutaneous late phase response to antigen. J. Allergy Clin. Immunol., 1994, 93, 484-493.
99. Norman P.S. - Immunotherapy for nasal allergy. J. Allergy Clin. Immunol., 1988, 84, 438-439.
100. O'Brien R.M., Byron K.A., Wootton A.M. et al. - Hyposensitization to the house dust mite (HDM) leads to a decrease in allergen-specific interferon-gamma (IFN-γ) and IL-4 expression by circulating T lymphocytes in allergic individuals. Allergy, 1995, 50 , 30 (Abst. OC - 066).
101. Okazaki M., Kitani H., Mifune T. et al. - Specific IgE, IgG and IgG4 antibodies against house dust mite in patients with bronchial asthma. Acta Med. Okayama, 1991, 45, 267-273.
102. Otsuka H., Mezawa A., Ohnishi M. et al. - Changes in nasal metachromatic cells during allergen immunotherapy. Clin. Exp. Allergy, 1991, 21, 115-119.
103. Pecquet C., Murrietta M., Michelen V. et al. - Blocking activity of mite-specific IgG antibodies studied by skin tests. Allergy, 1989, 44, 891-895.
104. Peng Z., Naclerio R.M., Norman P.S. & Adkinson N.F. - Quantitative IgE and IgG-subclass responses during and after long-term ragweed immunotherapy. J. Allergy Clin. Immunol., 1992, 89, 519-529.
105. Poulsen L.K., Sondergaard I. & Weeke B. - Improvement of specific immunotherapy by human IgG and modified allergens. Allergy, 1989, 44, 241-255.
106. Poulsen L.K., Lundberg L., Sondergaard I. & Weeke B. - Allergen-containing immune complexes used for immunotherapy of allergic asthma. II : IgE and IgG immune response during and after hyposensitization of sensitized guinea pigs. Allergy, 1991, 46, 292-303.
107. Quinti I., Brozek C., Wood N. et al. - Circulating IgG autoantibodies to IgE in atopic syndromes. J. Allergy Clin. Immunol., 1986, 77, 596-594
108. + B cells after rush immunotherapy in allergic patients. Allergy Clin. Immunol. News, 1994, S2, 807.
109. Ragazzini J.P., Moneret-Vautrin D.A. & Croizier A. - Immunothérapie spécifique (IS) aux venins d'hyménoptères. Suivi immunologique de 166 cas (intérêt du test de Maunsell, TM). Rev. Franc. Allergol., 1995, 35, 331.
110. Rak S., Björnson A., Häkanson L. et al. - The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J. Allergy Clin. Immunol., 1991, 88, 878-888.
111. Rihoux J.P., Melac M. & Henocq E. - Anti-IgE and anti-IgA-induced eosinophil migration in atopics and healthy volunteers. Clin. Exp. Allergy, 1990, 20 (S4), 11-18.
112. Ritter C., Bättig M., Kraemer R. et al. - IgE hidden in immune complexes with anti-IgE autoantibodies in children with asthma. J. Allergy Clin. Immunol., 1991, 88, 793-801.
113. Rogala B., Gumprech J., Rogala E. & Gawlik R. - The specific immunotherapy improves the platelets aggregation dysfunction in IgE-mediated allergy. Allergy, 1995, 50, 31 (Abst. OC - 070).
114. Romagnani S., Maggi E., Del Prete E. et al. - Role of interleukin-4 and gamma-interferon in the regulation of human IgE synthesis. Possible alterations in atopic patients. Int. Arch. Allergy Appl. Immunol., 1989, 88, 111-113.
115. Saint-Rémy J.M.R. - Immune modulation mediated by preformed antigen-antibody complexes. Its application to human immediate hypersensitivity diseases. Thèse de Doctorat, 1992, 1 Vol., 198 p .
116. Saint-Rémy J.M.R. - Novel approaches in immunotherapy. Clin. Rev. Allergy, 1994, 12, 23-42.
117. Schoen B., Buebl R., Vocks E. et al. - Serologic determination of immune parameters during immunotherapy of patients allergic to bee or wasp venom. J. Allergy Clin. Immunol., 1995, 95, 319 (Abst. 715).
118. Secrist H., Chelen C., Wen Y. et al. - Decreased IL-4 production in allergic individuals receiving allergen immunotherapy. J. Immunol., 1993, 150, 177A
119. Sehon A.H., Lee W.Y. - Suppression of IgE antibodies with modified antigens. J. Allergy Clin. Immunol., 1979, 64, 242-250.
120. Shakib F. - Is IgE-mediated hypersensitivity an autoimmune disease ? Allergy, 1990, 45, 1-9.
121. Shakib F., Mills C.S., Powell-Richards A. - The recognition of a recombinant human Fcε fragment by the subclasses of IgG autoanti-IgE. Disproportional subclass distribution of complexed autoantibody. Int. Arch. Allergy Immunol., 1992, 97, 243-248.
122. Shakib F., Smith S. & Pritchard D.I. - Do autoantibodies to IgE play a role in IgE-mediated events ? Immunol. Cell Biol., 1995, 73, 109-112.
123. Shalit M. & Levi-Schaffer F. - Challenge of mast cells with increasing amounts of antigen induces desensitization. Clin. Exp. Allergy, 1995, 25, 896-902.
124. Sin B., Misirugil Z., Aybay C. et al. - The effect of immunotherapy (IT) on natural killer (NK) cell activity in patients with respiratory allergy. Allergy, 1995, 50, 276 (Abst. P - 0579).
125. Smith S.J., Jones N.S. & Shakib F. - Circulating IgG autoanti-IgE antibodies in atopic patients block the binding of IgE to its low affinity receptor (CD23). J. Clin. Pathol. - Clin. Molec. Pathol., 1995, 48, M342-M346.
126. Sondergaard I., Kaergaard-Poulsen L., Osterballe O. & Weeke B. - A computational approach to the description of individual immune responses. IgE and IgG-subclass allergen-specific antibodies formed during immunotherapy. Allergy, 1991, 46, 10-19.
127. Squire E.N., McBride D.C., Ledoux R. et al. - Assessment of IgE-mediated sensitivity during immunotherapy. Comparison of the RAST with and without adsorption of IgG to titrated prick skin tests. Ann. Allergy, 1986, 56, 22-27.
128. Stadler B.M. - Immunoregulation by anti-immunoglobulin E autoantibodies. Adv. Allergy Clin. Immunol., 1992, 1 Vol., pp. 3-8.
129. Stampfli M.R., Rudolph M., Miescher S. et al. - Antigen-specific inhibition of IgE binding to the high-affinity receptor. J. Immunol., 1995, 155, 2948-2954.
130. Stephan V., Ruhr J. & Urbanek R. - Relevance of basophil histamine release changes during venom immunotherapy. Allergy, 1989, 44, 453-459.
131. Swainson J.A., Wilson P.B., Dore P. et al. - Evidence for circulating complexes containing IgE in patients with atopic dermatitis. Int. Arch. Allergy Clin. Immunol., 1985, 76, 237-242.
132. Tamir R., Castracane J.M. & Rocklin R.E. - Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis. J. Allergy Clin. Immunol., 1987, 79, 591-598.
133. Tamir R. & Pick A.L. - Immunological response to immunotherapy for immediate hypersensitivity. Clinical relevance. Clin. Immunol., 1988, 7, 256-264.
134. Till S.J., Corrigan C., Huston D. et al. - Grass pollen-induced IL-5 production by blood mononuclear cells (PBMC) is increased in allergic rhinitis and inhibited by immunotherapy. J. Allergy Clin. Immunol., 1996, 97, 245 (Abst. 250).
135. Tkaczuk J., Rance F., Juchet A. et al. - Very early effect of rush desensitization on blood T and B lymphocytes CD markers expression. Allergy, 1995, 50, 29 (Abst. OC - 064).
136. Tsai L.C., Tang R.B., Hung M.W. & Chang Z.N. - Changes in the levels of house dust mite specific IgG4 during immunotherapy in asthmatic children. Clin. Exp. Allergy, 1991, 21, 367-372.
137. Tsicopoulos A., Tonnel A.B., Wallaert B. et al. - Decrease of IgE-dependent platelet activation in hymenoptera hypersensitivity after specific rush desensitization. Clin. Exp. Immunol., 1988, 71, 433-438.
138. Tsicopoulos A., Tonnel A.B., Wallaert B. et al. - A circulating suppressive factor of platelet cytotoxic functions after rush immunotherapy in hymenoptera-venom hypersensitivity. J. Immunol., 1989, 142, 2683-2688.
139. Uhlin T., Nordvall S.L., Ohman S. et al. - Detailed IgE and IgG antibody patterns during immunotherapy with honey bee venom. Allergy, 1987, 42, 222-229.
140. Valacer D.J., O'Reilly M.E., Ilowite N.T. et al. - Identification of anti-idiotypic antibodies in the sera of rye grass-allergic and non allergic individuals. J. Allergy Clin. Immunol., 1991, 88, 349-355.
141. Van der Giessen M., Hohman W.L., Van Kernebeek G. et al. - Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy. Int. Arch. Allergy Appl. Immunol., 1976, 50, 625-640.
142. Varney V.A., Hamid Q., Gaga M. - Effects of grass pollen immunotherapy on cytokine mRNA expression during allergen-induced late cutaneous responses. J. Clin. Invest., 1993, 92, 644-651.
143. Vassella C.C., Odelram H., Kjellman N.I.M. et al. - High anti-IgE levels at birth are associated with a reduced allergy prevalence in infants at risk. A prospective study. Clin. Exp. Allergy, 1994, 24, 771-777.
144. Vesterinen E., Sorva R., Kalliomaki P. et al. - The effects of rush immunotherapy (RIT) on blood mononuclear cells. Allergy, 1995, 50, 29 (Abst. OC - 065).
145. Visco V., Denepoux S., Dolecek C. et al. - Characterization of human IgG anti-Bet V I monoclonal antibodies which interfere with allergen recognition by patients IgE. Allergy, 1995, 50, 28 (Abst. OC - 061).
146. Visco V., Lebecque S., Lemao J. et al. - An anti-Bet V I human IgG monoclonal antibody significantly inhibits the allergen-induced histamine release from 4 birch pollen-sensitive patients. Allergy, 1995, 50, 28 (Abst. OC - 062).
147. Wantke F., Götz M., Jarish J. - Spontaneous histamine release in whole blood in patients before and after 4 months of specific immunotherapy. Clin. Exp. Allergy, 1993, 23, 992-995.
148. Weller M., Snoek M., Weller F. et al. - Effect of immunotherapy on the late phase skin reaction. Allergy Clin. Immunol. News, 1994, S2, 278.
149. Williams R.C., Griffiths R.W., Emmons J.D. et al. - Naturally occurring human antiglobulins with specificity for IgE. J. Clin. Invest., 1972, 51, 955-964.
150. Wilson P.B., Fairfield J.E. & Beech N. - Detection of IgG subclass-specific anti-IgE antibodies in normal and atopic individuals. Int. Arch. Allergy Appl. Immunol., 1987, 84, 198-204.
151. Witteman A.M., Stapel S.O., Sjamsoedin D.H.S. et al. - Fel d 1-specific IgG antibodies induced by natural exposure have blocking activity in skin tests. Int. Arch. Allergy Immunol., 1996, 109, 369-375.
152. Yamauchi N., Ito K., Suko M. et al. - IgG2 antibodies block IgE antibody-induced asthma in guinea pigs. Int. Arch. Allergy Appl. Immunol., 1986, 80, 76-80.
153. Yu Y., De Weck A.L., Stadler B.M. et al. - Anti-IgE autoantibodies and bee-sting allergy. Allergy, 1995, 50, 119-125.
154. Zeiss C.R., Metzger L., Levitz D. - Quantitative relationship between IgE antibody and blocking antibodies specific for antigen E in patients given immunotherapy with ragweed antigen E. Clin. Exp. Immunol., 1977, 28, 250-255.